What is it about?

A recent progress on epigenetic drugs that could possibly be used against the most common malignant tumors of childhood, such as medulloblastomas, high-grade gliomas and ependymomas.

Featured Image

Why is it important?

Advanced epigenetic drugs target specific epigenetic alterations of the brain tumor molecular profile.

Read the Original

This page is a summary of: Advances on Epigenetic Drugs for Pediatric Brain Tumors, Current Neuropharmacology, July 2023, Bentham Science Publishers, DOI: 10.2174/1570159x20666220922150456.
You can read the full text:

Read

Contributors

The following have contributed to this page